Target intelligence / Profile preview

Hemoglobin-digesting protease cascade

Molecular classification
Enzyme, Protease, Aspartic protease (e.g., plasmepsins, cathepsin D), Cysteine protease (e.g., cathepsin B, cathepsin L, falcipains), Metallo-protease, Aminopeptidase
01

Overview

Hemoglobin digestion is a critical biochemical process for blood-feeding parasites such as ticks and Plasmodium (the causative agent of malaria), enabling them to extract essential nutrients from host hemoglobin. This catabolic process is driven by a coordinated cascade of intracellular proteases, including aspartic, cysteine, and metalloproteases, which break down hemoglobin at acidic pH, commonly found within digestive vacuoles. Inhibiting these proteases blocks parasite development, making them validated therapeutic targets for antimalarial and anti-tick strategies. However, "hemoglobin digestion" does not refer to a single molecule or receptor, but rather a process governed by several enzymes that should be considered individually as molecular targets.

Other names
Hemoglobinolytic cascadeHemoglobin catabolismHemoglobin proteolysis
02

Mechanism of action

Inhibition of hemoglobin-digesting proteases prevents parasites from metabolizing host hemoglobin, starving them of nutrients and halting development

03

Biological functions

Protein degradationNutrient acquisitionHeme detoxificationAmino acid generationParasite growth and development
04

Disease associations

Infection (malaria, tick-borne disease, and other blood-feeding parasite infections)Other (role in iron homeostasis and hemolytic disorders)
05

Safety considerations

Off-target effects of broad-spectrum protease inhibitorsPotential for hemolysis or disrupted iron homeostasis in hostEmergence of drug resistance in parasites
06

Interacting drugs

Protease inhibitors (e.g., E64, pepstatin A, leupeptin—experimental inhibitors of hemoglobin-digesting enzymes)

1 more in the full profile.

07

Biomarkers

Activity of hemoglobin-derived proteases (e.g., expression or activity of plasmepsins and falcipains in malaria parasites is a readout for drug efficacy)Levels of hemoglobin or its breakdown products (e.g., heme, bilirubin in clinical settings)

Beyond the preview

Go deeper on Hemoglobin-digesting protease cascade.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoglobin-digesting protease cascade.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call